Market Size of Contrast Media Injectors Industry
Study Period | 2021 - 2029 |
Market Size (2024) | USD 1.82 Billion |
Market Size (2029) | USD 2.59 Billion |
CAGR (2024 - 2029) | 7.44 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Contrast Media Injectors Market Analysis
The Contrast Media Injectors Market size is estimated at USD 1.82 billion in 2024, and is expected to reach USD 2.59 billion by 2029, growing at a CAGR of 7.44% during the forecast period (2024-2029).
The COVID-19 pandemic has had a devastating impact on the global population's health and a significant economic impact on most countries. The volume of imaging cases in many radiology departments dropped dramatically. The COVID-19 outbreak impacted patients' access to healthcare facilities as the pandemic forced them to wait for lifesaving imaging procedures. The pandemic also increased the waiting time for patients to have their imaging done. According to an article published by the Radiology Society of North America in April 2020, the COVID-19 pandemic profoundly impacted radiology practices across the country. The volume of diagnostic imaging and the number of CT and MRI machines installed will primarily determine the demand for contrast injectors. The easing of norms and the start of vaccination programs led to a recovery in the contrast media injectors market.
The major factors attributed to the growth of the contrast media injectors market are increasing demand for minimally invasive surgeries, technological advancements, and increasing regulatory approvals. Several advancements in contrast media injector technology have been made to reduce contrast media waste and automate data collection regarding the dose received by a patient. For example, the automated injector systems precisely collect the amount of contrast media used. Vendors offer personalized doses to patients, using the information pulled from EMR or picture archiving and communication systems (PACS). One such advancement in reducing contrast media waste is syringeless injectors.
According to the WHO updates from July 2021, cardiovascular diseases (CVDs) are the number one cause of death globally. An estimated 17.9 million each year suffer from cardiovascular diseases. Four out of five cardiovascular deaths are due to strokes and heart attacks, and one-third of deaths occur prematurely in people under 70 years. Similarly, according to the WHO 2021 fact sheet, non-communicable diseases (NCDs), also known as chronic diseases, are responsible for the death of about 41 million people each year, which was about 71% of the total deaths recorded all over the world. As per the same source, every year, over 15 million people aged between 30-69 years die due to NCDs across the world. Thus, due to the high burden of mortality due to NCDs, the demand for diagnostic procedures is increasing. As minimally invasive procedures have more advantages over traditional procedures, they are gaining traction, and thereby, the demand for contrast media injectors is expected to increase.
Most companies are developing innovative products to reduce contrast media waste and gain a competitive advantage. Bracco has developed smart syringeless injectors, which can use every drop of contrast loaded into the system for maximum economy. Smart injectors record the amount injected and the imaging protocol used and send the information to the PACS. These constant technological advancements in contrast to media injector technology are expected to boost the market during the forecast period.
However, the high cost of contrast media injectors and adverse effects of contrast agents are expected to plummet the growth of the market over the forecast period.
Contrast Media Injectors Industry Segmentation
Contrast media injectors (CMI) are devices employed for injecting contrast media into the body to improve the visibility of tissues for medical imaging procedures. The contrast media injectors market is segmented by Product (Injector System and Consumables), Type of Injectors (Single-head Injectors, Dual-head Injectors, and Syringeless Injectors), Application (Radiology, Interventional Cardiology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Products | |||||
| |||||
|
By Type of Injectors | |
Single-head Injectors | |
Dual-head Injectors | |
Syringeless Injectors |
By Application | |
Radiology | |
Interventional Cardiology | |
Other Applications |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Contrast Media Injectors Market Size Summary
The contrast media injectors market is poised for significant growth, driven by the increasing demand for minimally invasive surgeries and technological advancements in the field. The market is recovering from the setbacks caused by the COVID-19 pandemic, which had previously disrupted access to healthcare and reduced the volume of imaging cases. The resurgence in demand is fueled by the rising prevalence of chronic diseases, such as cardiovascular conditions, which necessitate diagnostic procedures. Technological innovations, such as automated and syringeless injectors, are enhancing the efficiency and precision of contrast media usage, thereby reducing waste and improving patient outcomes. These advancements, coupled with regulatory approvals, are expected to propel the market forward during the forecast period.
North America is anticipated to lead the market, supported by a growing preference for minimally invasive procedures and a high incidence of chronic diseases. The region's dominance is further bolstered by technological advancements and increased healthcare expenditure by key players. The market is characterized by a few major players, including Bracco Group, GE Healthcare, and Bayer HealthCare, who are actively engaging in strategic collaborations and product innovations to maintain their competitive edge. Despite challenges such as high costs and potential adverse effects of contrast agents, the market is expected to expand, with new entrants likely to emerge as the demand for advanced imaging solutions continues to rise.
Contrast Media Injectors Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Demand for Minimally Invasive Surgeries
-
1.2.2 Technological Advancements and Increasing Number of Regulatory Approvals
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Contrast Media Injectors
-
1.3.2 Adverse Effects of Contrast Agents
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Products
-
2.1.1 Injector Systems
-
2.1.1.1 CT Injector Systems
-
2.1.1.2 MRI Injector Systems
-
2.1.1.3 Cardiovascular/Angiography Injector Systems
-
-
2.1.2 Consumables
-
2.1.2.1 Tubing
-
2.1.2.2 Syringe
-
2.1.2.3 Other Consumables
-
-
-
2.2 By Type of Injectors
-
2.2.1 Single-head Injectors
-
2.2.2 Dual-head Injectors
-
2.2.3 Syringeless Injectors
-
-
2.3 By Application
-
2.3.1 Radiology
-
2.3.2 Interventional Cardiology
-
2.3.3 Other Applications
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Contrast Media Injectors Market Size FAQs
How big is the Contrast Media Injectors Market?
The Contrast Media Injectors Market size is expected to reach USD 1.82 billion in 2024 and grow at a CAGR of 7.44% to reach USD 2.59 billion by 2029.
What is the current Contrast Media Injectors Market size?
In 2024, the Contrast Media Injectors Market size is expected to reach USD 1.82 billion.